Everforth (EFOR) Earnings Analysis
Everforth (EFOR) next reports earnings on 2026-07-29, consensus EPS 0.81 USD. Last quarter (2026-04-22) it missed with EPS 0.69 USD vs 0.98 USD est (-29.6%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 9.02.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EFOR next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 0.81 USD |
| Revenue estimate | 0.99B |
EFOR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.69 USD | 0.98 USD | -29.6% | Miss |
| 2026-02-04 | 1.15 USD | 1.18 USD | -2.5% | Miss |
| 2025-10-22 | 1.31 USD | 1.22 USD | +7.4% | Beat |
| 2025-07-23 | 1.17 USD | 1.08 USD | +8.3% | Beat |
| 2025-02-05 | 1.28 USD | 1.21 USD | +5.8% | Beat |
| 2024-07-24 | 1.36 USD | 1.33 USD | +2.3% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
EFOR valuation and analyst view
| Trailing P/E | 9.02 |
|---|---|
| Trailing EPS | 2.375 USD |
| Price / book | 0.47 |
| Dividend yield | 0.00% |
| Market cap | 0.83B |
| Analyst consensus | Hold (4 buy / 7 hold / 1 sell) |
| Avg price target | 29 USD |
Related research pages
Frequently asked questions
When is Everforth (EFOR)'s next earnings date?
Everforth is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.81 USD and revenue estimate of 0.99B.
Did EFOR beat earnings last quarter?
In its 2026-04-22 report, EFOR posted EPS of 0.69 USD versus a 0.98 USD estimate — a miss of 29.6%.
What is EFOR's earnings track record?
Over the last 6 reported quarters with consensus data, EFOR beat estimates 4 times (67%).
What is EFOR's current P/E ratio and EPS?
EFOR trades at a trailing P/E of 9.02 on trailing EPS of 2.375302663438257 USD.
What do analysts rate EFOR?
Analyst consensus is "Hold" across 12 ratings (0 strong buy, 4 buy, 7 hold, 1 sell, 0 strong sell). Average 12-month price target: 29 USD.